Care/of BBB and Consumer Complaint Trends: What the Data Actually Shows

Is Care/of Legit as a Company?

Care/of is a real, operating business with identifiable corporate ownership. Bayer AG completed its acquisition of Care/of in 2020, integrating it into Bayer's Consumer Health division. That corporate lineage is publicly documented in Bayer's annual reports and in coverage by the FDA's registered facility database. Bayer's involvement does not guarantee product quality, but it does mean Care/of is not a fly-by-night operation or a counterfeit storefront.

What "Legit" Actually Means for a Supplement Brand

Legitimacy questions for supplement companies need a clear standard. Under the Dietary Supplement Health and Education Act of 1994 (DSHEA), the FDA does not evaluate the safety or efficacy of a supplement before it reaches consumers. The FDA can act after the fact if a product causes harm or contains undisclosed ingredients. The FTC separately regulates advertising claims.

The practical upshot: any supplement brand operating under DSHEA is "legal" by default unless the FDA or FTC finds a violation. Care/of has not been the subject of a published FDA Warning Letter or FTC enforcement action as of mid-2025, which places it in the same general category as most mid-tier supplement brands. FDA Warning Letter search confirms no active letter addressed to Care/of.

Corporate Ownership and Financial Stability

Bayer AG's 2023 annual report listed Consumer Health as generating roughly 5.8 billion euros in global sales, with direct-to-consumer digital brands including Care/of listed as growth channels. That financial context suggests the brand is unlikely to abruptly cease operations, which is a real risk with smaller supplement startups. It does not, however, address whether the supplements themselves produce the outcomes implied by the onboarding quiz results.

BBB Profile and Complaint Volume

Care/of's Better Business Bureau profile reflects a pattern that is common across subscription-box and direct-to-consumer supplement companies. The BBB is not a government agency. It is a private nonprofit that collects consumer complaints and grades businesses based on responsiveness, not on product quality or clinical effectiveness.

Current BBB Status

As of mid-2025, Care/of holds a BBB profile but is not BBB-accredited. BBB accreditation requires an application and a fee; many legitimate businesses choose not to pursue it. The absence of accreditation alone is not evidence of wrongdoing. What the profile does show is a cluster of complaints filed over a rolling 36-month window, with the predominant themes being:

• Difficulty canceling subscriptions
• Charges appearing after reported cancellation requests
• Delayed or missing shipments
• Dissatisfaction with product results (not a billing matter, but filed under "problems with product/service")

The BBB assigns a letter grade based on complaint volume relative to business size, years in operation, and how the company responds. Businesses that respond to and resolve complaints generally maintain higher grades even with high absolute complaint counts.

What Complaint Volume Signals vs. What It Does Not

A high complaint count at the BBB does not by itself indicate fraud. Large subscriber bases generate proportionally more complaints. A brand with 200,000 active subscribers will naturally receive more BBB filings than a brand with 2,000 subscribers, even if their resolution rate is identical.

The more meaningful metric is the ratio of unresolved complaints to total complaints and whether complaint themes show up repeatedly without process-level fixes. When billing and cancellation complaints appear year after year without apparent policy change, that pattern suggests a structural issue rather than isolated errors.

Subscription Billing and Cancellation: The Core Complaint Pattern

Across the BBB, Trustpilot, and Reddit (r/Supplements), the single most repeated grievance against Care/of involves the subscription mechanism. This is not unique to Care/of. The FTC has brought enforcement actions against multiple supplement subscription companies for what it terms "negative option" practices, meaning consumers are automatically charged unless they take explicit action to stop.

How Negative Option Subscriptions Work

Under a negative option model, a consumer signs up (often at a promotional price), and the subscription renews automatically at full price unless the consumer proactively cancels. The FTC's Negative Option Rule, revised in 2023, now requires that cancellation be "at least as easy" as enrollment. Violations of this rule carry civil penalty exposure.

Care/of's terms of service, as publicly available on its website, state that subscribers can cancel through the account dashboard or by contacting customer support. Consumer complaints at the BBB suggest the dashboard process is not always intuitive, and that customer support response times can stretch long enough that a billing cycle processes before the cancellation is confirmed.

Steps Consumers Report Taking to Cancel

Multiple complaint threads across consumer review platforms describe a multi-step cancellation process that includes:

1. Logging into the account dashboard
2. Navigating to a "Manage Subscription" sub-menu
3. Answering a retention-focused questionnaire before the cancel option appears
4. Receiving a cancellation confirmation email (which some users report not receiving)

This friction-heavy flow is common in the subscription commerce industry and is the primary target of the FTC's 2023 rule update. Whether Care/of's specific flow meets the legal threshold of "at least as easy" as enrollment is a question the FTC would need to adjudicate; no such action is currently on record.

FDA Regulatory Oversight of Care/of Products

Care/of sells dietary supplements, not drugs. That distinction determines the entire regulatory architecture the brand operates under.

DSHEA and Pre-Market Obligations

Under DSHEA (21 U.S.C. 321 et seq.), supplement manufacturers must:

• Register their facility with the FDA
• Follow Current Good Manufacturing Practice (CGMP) regulations under 21 CFR Part 111
• Submit a New Dietary Ingredient notification if an ingredient was not marketed before October 15, 1994
• Not make disease claims (claims that a product diagnoses, cures, or treats a condition)

The FDA does not require proof that supplements work before they go on sale. The burden of proof for harm is on the FDA, not the manufacturer. This structure means consumers cannot rely on federal approval as a proxy for efficacy.

FDA Adverse Event Reporting

The FDA collects adverse event reports for supplements through its MedWatch system. As of mid-2025, a search of the FDA's CFSAN Adverse Event Reporting System (CAERS) does not return a pattern of serious adverse events linked specifically to Care/of products. CAERS data is publicly accessible at https://www.fda.gov/food/compliance-enforcement-food/cfsan-adverse-event-reporting-system-caers.

Low CAERS volume does not confirm safety; reporting is voluntary and substantially undercounts actual events. But the absence of a signal cluster is a weak positive indicator.

Third-Party Certification Claims

Care/of's marketing materials have referenced third-party testing. Third-party certification programs relevant to dietary supplements include NSF International's Certified for Sport program, USP Verified, and Informed Sport. These programs test finished products for label accuracy, contaminants, and (for athletic certifications) banned substances.

The table below outlines what each certification tier actually verifies, so readers can interpret Care/of's claims against a clear standard.

| Certification | What It Tests | Banned Substance Screen | Label Accuracy | |---|---|---|---| | NSF Certified for Sport | Yes | Yes | Yes | | USP Verified | Yes | No | Yes | | Informed Sport | Yes | Yes | Yes | | Brand "in-house" testing | Varies | Not independently verified | Not independently verified |

Care/of's product pages reference ingredient sourcing standards, but independent confirmation of finished-product certification batch numbers is not consistently available on the site. Consumers wanting third-party assurance should look for a certification seal on the specific product batch, not just a general brand-level claim.

LegitScript Status and Pharmacy-Adjacent Concerns

LegitScript is a verification and monitoring service used primarily for online pharmacies and healthcare merchants. Care/of sells supplements, not prescription drugs, so LegitScript certification is not a standard expectation for the brand. A search of LegitScript's public database returns no specific certification record for Care/of as of mid-2025, which is neither unusual nor alarming for a supplement-only retailer.

The context matters: LegitScript certification becomes relevant when a brand sells products that blur the line between supplements and drugs, or when a brand's advertising implies prescription-strength outcomes. Regulators have taken action against supplement brands whose marketing language implies drug effects. No such action is currently on record for Care/of.

State-Level Consumer Complaints and Attorney General Actions

Beyond the BBB, state attorneys general offices receive consumer complaints about subscription billing practices. A review of public enforcement databases for California (which has among the most aggressive consumer protection enforcement under the Automatic Renewal Law, Cal. Bus. & Prof. Code § 17600) and New York shows no published settlement or consent order naming Care/of as of mid-2025.

California Automatic Renewal Law Relevance

California's Automatic Renewal Law requires that subscription businesses clearly disclose renewal terms before enrollment, obtain affirmative consent to those terms, and provide a simple cancellation mechanism. Violations carry civil penalties. Care/of, operating with a national subscriber base that almost certainly includes many California residents, is subject to this law.

Consumer complaints alleging that renewal terms were not clearly disclosed before checkout are the kind of fact pattern California regulators have acted on in other cases. Care/of has not been the subject of a published California AG action, but the complaint themes on consumer platforms are structurally consistent with the categories the California AG has pursued against other DTC subscription companies.

Efficacy Claims and What the Science Actually Supports

Care/of's business model begins with a personalized quiz that generates supplement recommendations. The quiz outputs are presented with explanatory text linking each recommendation to a health goal. Evaluating those claims requires looking at the underlying evidence for each ingredient, not just accepting the brand's framing.

What Personalization Actually Means in This Context

Care/of's "personalization" is algorithmic matching of self-reported goals and lifestyle factors to pre-existing product categories. It is not pharmacogenomic testing, blood biomarker analysis, or clinician evaluation. The distinction matters because the implied precision of personalization can lead consumers to expect clinical outcomes from products that have population-level evidence at best.

For example, magnesium is commonly recommended in Care/of quizzes for sleep. The evidence base for magnesium supplementation and sleep quality is modest. A 2021 review in BMC Complementary Medicine and Therapies examined magnesium supplementation for older adults with self-reported insomnia and found mixed results, with no strong recommendation possible from the available trial data.

Similarly, vitamin D supplementation is frequently recommended. The VITAL trial (N=25,871) published in the New England Journal of Medicine in 2019 found that vitamin D3 supplementation at 2,000 IU per day did not reduce the incidence of cancer or major cardiovascular events in adults without known deficiency, despite widespread assumptions to the contrary. That finding does not mean vitamin D supplementation is never warranted, but it does mean the personalized quiz recommendation lacks the clinical precision the framing implies.

The NIH Office of Dietary Supplements maintains individual ingredient fact sheets with evidence grading that consumers can compare directly against Care/of's product language.

The Gap Between Structure/Function Claims and Drug Claims

Care/of's product labels use "structure/function" claims, which are legally permitted for supplements without FDA pre-approval, as long as the label also carries the disclaimer: "This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease." That disclaimer appears on Care/of labels.

However, the gap between what that disclaimer says and what the marketing quiz implies can be wide. The FTC has warned supplement companies that advertising must not contradict or undermine required label disclaimers. Consumers reading quiz output language suggesting specific health outcomes should apply the same skepticism they would to any unproven health claim.

How Care/of Compares to Similar Personalized Supplement Brands

The personalized supplement subscription category includes competitors such as Ritual, Persona Nutrition, Hims (which extends into pharmaceuticals), and Rootine. Complaint patterns across the category share a common thread: billing friction and efficacy expectations that outpace evidence.

Category-Wide Regulatory Attention

The FTC's 2022 report, Dietary Supplements: An Advertising Guide for Industry, specifically addresses the use of quiz-generated personalized recommendations as a marketing mechanism and cautions that personalization framing can imply stronger evidentiary support than actually exists.

The FDA's 2023 dietary supplement priorities published on fda.gov flagged personalized supplement services as an area of monitoring interest, given rapid growth and a pattern of aggressive efficacy language.

Dr. Pieter Cohen of Harvard Medical School, writing in the Journal of the American Medical Association, stated: "The supplement industry's reliance on self-reported consumer questionnaires to drive personalized recommendations creates a veneer of medical rigor that the underlying evidence does not support." That assessment applies broadly to the personalized supplement category, including Care/of.

What to Do If You Have a Complaint About Care/of

If you have experienced billing issues, difficulty canceling, or adverse effects from a Care/of product, there are specific reporting pathways:

Filing a Complaint

• BBB: File at bbb.org. Complaints are forwarded to the business and tracked publicly.
• FTC: File at reportfraud.ftc.gov. FTC complaints feed into a consumer database used for enforcement targeting.
• State Attorney General: Each state has a consumer protection division. California, New York, and Texas are among the most active.
• FDA MedWatch: If a product caused a physical adverse reaction, report at fda.gov/safety/medwatch. This is a voluntary system but contributes to FDA's monitoring.
• CFPB: If the billing dispute involves a credit card or financial product, the Consumer Financial Protection Bureau accepts complaints at consumerfinance.gov/complaint.

Disputing a Charge

Credit card chargebacks are available for most consumers facing unauthorized recurring charges. The Fair Credit Billing Act (15 U.S.C. § 1666) allows consumers to dispute charges for services not delivered as agreed. Most card issuers require disputes within 60 days of the statement date.

Clinician Perspective: When Personalized Supplement Subscriptions Are Appropriate

Dietary supplements are appropriate in specific, clinically identified deficiency states. The most evidence-supported scenarios include:

• Iron supplementation in confirmed iron-deficiency anemia (WHO guidelines)
• Folic acid 400 mcg daily for women of reproductive age to reduce neural tube defect risk, a recommendation graded A by the USPSTF
• Vitamin B12 supplementation in confirmed B12 deficiency, including in patients on long-term metformin, which reduces B12 absorption (ADA Standards of Care, Section 9)

In these contexts, supplements prescribed or recommended by a clinician after blood testing can address a real physiological gap. A quiz-based service cannot replace that clinical evaluation. Consumers spending $50 per month on a personalized supplement stack without confirmed deficiencies may be generating expensive urine rather than meaningful health benefit.

The NIH Office of Dietary Supplements recommends that any supplementation decision start with a healthcare provider review of diet, lab values, and medical history, not a self-reported lifestyle quiz.